Complications of spinal fusion with utilization of bone morphogenetic protein: A systematic review of the literature

Spine

Volumn 39, Issue 1, 2014, Pages 91-101

  Singh, Kern ^a   Ahmadinia, Kasra ^a   Park, Daniel K ^b   Nandyala, Sreeharsha V ^a   Marquez Lara, Alejandro ^a   Patel, Alpesh A ^c   Fineberg, Steven J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bone morphogenetic protein; Cervical; Complications; Fusion; Lumbar

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ANTERIOR LUMBAR INTERBODY FUSION; ARTICLE; CERVICAL SPINE; CERVICAL SPINE ANTERIOR FUSION; DATA EXTRACTION; DYSPHAGIA; DYSPNEA; ECTOPIC BONE FORMATION; HUMAN; INFECTION; INFECTION COMPLICATION; LUMBAR SPINE; MEDLINE; NEUROLOGICAL COMPLICATION; OSSIFICATION; OSTEOLYSIS; PNEUMONIA; POSTERIOR CERVICAL FUSION; POSTERIOR LUMBAR INTERBODY FUSION; POSTEROLATERAL LUMBAR FUSION; PRIORITY JOURNAL; PSEUDARTHROSIS; RETROGRADE EJACULATION; SPINE FUSION; SPINE SURGERY; SWELLING; SYSTEMATIC REVIEW; TRANSFORAMINAL LUMBAR INTERBODY FUSION; WOUND COMPLICATION;

BONE MORPHOGENETIC PROTEINS; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; SPINAL FUSION; SPINE;

EID: 84893016187     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000004     Document Type: Article

References (44)

1. Buttermann GR . Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion . Spine J 2008;8:426-35
2. Lanman TH, Hopkins TJ . Early fi ndings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(l-lactide-co- d, l -lactide) bioabsorbable implants . Neurosurg Focus 2004;16:E6
3. Lu DC, Tumialan LM, Chou D . Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: A comparison of dysphagia rates and outcomes in 150 patients . J Neurosurg Spine 2013;18:43-9
4. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein- 2 use in anterior cervical spine fusion . Spine (Phila Pa 1976) 2006;31:542-7
5. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine . Spine (Phila Pa 1976) 2006;31:2813-9
6. Tumialan LM, Pan J, Rodts GE, et al. The safety and effi cacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: A review of 200 patients . J Neurosurg Spine 2008;8:529-35
7. Vaidya R, Weir R, Sethi A, et al. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence . J Bone Joint Surg Br 2007;89:342-5
8. Delawi D, Dhert WJ, Rillardon L, et al. A prospective, randomized, controlled, multicenter study of osteogenic protein-1 in instrumented posterolateral fusions: Report on safety and feasibility . Spine (Phila Pa 1976) 2010;35:1185-91
9. Garrett MP, Kakarla UK, Porter RW, et al. Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions . Neurosurgery 2010;66:1044-9;discussion 9
10. Glassman SD, Howard J, Dimar J, et al. Complications with recombinant human bone morphogenic protein-2 in posterolateral spine fusion: A consecutive series of 1037 cases . Spine (Phila Pa 1976) 2011;36:1849-54
11. Hoffmann MF, Jones CB, Sietsema DL . Adjuncts in posterior lumbar spine fusion: Comparison of complications and effi cacy . Arch Orthop Trauma Surg 2012;132:1105-10
12. Lee KB, Taghavi CE, Hsu MS, et al. The effi cacy of rhBMP-2 versus autograft for posterolateral lumbar spine fusion in elderly patients. Eur Spine J 2010;19:924-30
13. Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating the safety and effi cacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis . Spine (Phila Pa 1976) 2004;29:1885-92
14. Crawford CH, 3rd, Carreon LY, McGinnis MD, et al. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis . Spine (Phila Pa 1976) 2009;34:1390-4
15. Haid RW, Jr, Branch CL, Jr, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages . Spine J 2004;4:527 - 38;discussion 38-9
16. Helgeson MD, Lehman RA, Jr, Patzkowski JC, et al. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion . Spine J 2011;11:507-10
17. Hiremath GK, Steinmetz MP, Krishnaney AA . Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion ? Spine (Phila Pa 1976) 2009;34:885-9
18. Hodges SD, Eck JC, Newton D . Retrospective study of posterior cervical fusions with rhBMP-2 . Orthopedics 2012;35:e895-8
19. Joseph V, Rampersaud YR . Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: A CT analysis . Spine (Phila Pa 1976) 2007;32:2885-90
20. Knox JB, Dai JM, 3rd, Orchowski J . Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2 . Spine (Phila Pa 1976) 2011;36:672-6
21. Kuklo TR, Rosner MK, Polly DW, Jr . Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion . Neurosurg Focus 2004;16:E10
22. Mannion RJ, Nowitzke AM, Wood MJ . Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2-but what is the cost ? Spine J 2011;11 : 527-33
23. Owens K, Glassman SD, Howard JM, et al. Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion. Eur Spine J 2011;20:612-7
24. Rihn JA, Patel R, Makda J, et al. Complications associated with single-level transforaminal lumbar interbody fusion . Spine J 2009;9:623-9
25. Villavicencio AT, Burneikiene S, Nelson EL, et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2 . J Neurosurg Spine 2005;3:436-43
26. Vaidya R, Carp J, Sethi A, et al. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2 . Eur Spine J 2007;16:1257-65
27. Schultz DG. Life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. In Notifi cation FPH ed, 2008
28. Lanman TH, Hopkins TJ . Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly (l -lactide-co- d, l -lactide) bioresorbable implants . Neurosurg Focus 2004;16:E9
29. Cahill KS, Chi JH, Day A, et al. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures . JAMA 2009;302:58-66
30. Acosta FL, Cloyd JM, Aryan HE, et al. Patient satisfaction and radiographic outcomes after lumbar spinal fusion without iliac crest bone graft or transverse process fusion . J Clin Neurosci 2009;16:1184-7
31. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages . J Spinal Disord Tech 2002;15:337-49
32. Carragee EJ, Mitsunaga KA, Hurwitz EL, et al. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: A cohort controlled study . Spine J 2011;11:511-6
33. Lindley EM, McBeth ZL, Henry SE, et al. Retrograde ejaculation after anterior lumbar spine surgery . Spine (Phila Pa 1976) 2012;37:1785-9
34. Hu R, Hearn T, Yang J . Bone graft harvest site as a determinant of iliac crest strength . Clin Orthop Relat Res 1995;310:252-6
35. Younger EM, Chapman MW . Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-5
36. Fernyhough JC, Schimandle JJ, Weigel MC, et al. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion . Spine 1992;17:1474-80
37. Ahlmann E, Patzakis M, Roidis N, et al. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes . J Bone Joint Surg Am 2002;84- A:716-20
38. Banwart JC, Asher MA, Hassanein RS . Iliac crest bone graft harvest donor site morbidity. A statistical evaluation . Spine 1995;20 : 1055-60
39. Kaiser MG, Haid RW, Jr, Subach BR, et al. Comparison of the miniopen versus laparoscopic approach for anterior lumbar interbody fusion: A retrospective review . Neurosurgery 2002;51:97-103;discussion 5
40. Jarrett CD, Heller JG, Tsai L . Anterior exposure of the lumbar spine with and without an "access surgeon": Morbidity analysis of 265 consecutive cases . J Spinal Disord Tech 2009;22:559-64
41. Kang BU, Choi WC, Lee SH, et al. An analysis of general surgeryrelated complications in a series of 412 minilaparotomic anterior lumbosacral procedures . J Neurosurg Spine 2009;10:60-5
42. Schultz DU. Food and Drug Administration, Department of Health and Human Services, Center for Devices and Radiological Health. InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Devices - P000058. Summary of safety and effectiveness data. 2002
43. Boakye M, Mummaneni PV, Garrett M, et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein . J Neurosurg Spine 2005;2:521-5
44. Arnold PM, Bryniarski M, McMahon JK . Posterior stabilization of subaxial cervical spine trauma: Indications and techniques . Injury 2005;36:S36-43.